Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02860884

Acronym

NASH

Enrollment

136

Registered

2016-08-09

Start date

2014-08-31

Completion date

2015-10-31

Last updated

2016-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatty Liver, Non-alcoholic Fatty Liver Disease

Brief summary

The main objective of this study is to evaluate the ability of infrared spectroscopy to discriminate simple hepatic steatosis from NASH

Interventions

PROCEDUREliver biopsy

OTHERinfrared spectroscopy

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients who have undergone a liver biopsy for simple fatty liver or NASH and for which a serum sample is serum bank * Men or Women * aged of 18 years or more * After giving their consent to participate in research

Exclusion criteria

* Known Cancer * Refusal of consent * Inflammatory disease

Design outcomes

Primary

Measure	Time frame	Description
Sensitivity	through study completion, an average of 1 year	Evaluation of the ability of infrared spectroscopy to discriminate simple hepatic steatosis from NASH with liver biopsy as a gold standard

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026